In this conversation with Adriane Fugh-Berman, an expert on pharmaceutical marketing and disease definition, she dives into how corporations shape our understanding of diseases. From the rebranding of pre-diabetes to the medicalization of menopause, Adriane highlights the insidious influence of pharma on health narratives. The discussion reveals how marketing strategies distort disease definitions and impact prescribing practices, all while advocating for transparency in healthcare. A thought-provoking chat that questions who controls our health decisions!